|
HS Code |
572523 |
As an accredited Methyl 4-Bromo-3-Fluorobenzoate 98 factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Methyl 4-Bromo-3-Fluorobenzoate 98 prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemists searching for powerful intermediates often run into a unique, almost paradoxical problem: the gold-standard compounds for drug and agrochemical building blocks remain tricky to source with both purity and consistency. Methyl 4-Bromo-3-Fluorobenzoate 98, known for its high assay and targeted substitution pattern, stands apart from the crowd for several reasons rooted in how modern chemical process design continues to evolve.
The structure of this product—bearing both a bromine and a fluorine atom on the benzoate ring—might not look particularly special at first glance. It’s only through actual hands-on synthesis work that the value reveals itself. In the pharmaceutical industry, introducing both bromine and fluorine onto a benzene core isn’t just a matter of creativity; it’s about what these atoms bring to the table: reactivity, stability, and selectivity. Both substitutions allow researchers to fine-tune the electronic features of target molecules, shape metabolic stability, and lay the foundation for scaled drug development work where the smallest modifications can spell success or failure in a drug candidate.
Graduate school labs and manufacturing process teams alike have their work cut out for them. Fluorination often raises the activation barrier in target molecules, which means reactions take a different pathway. Bromine—being bulkier and more reactive than chlorine—offers a complementary handle for Suzuki, Heck, or Buchwald-Hartwig cross-coupling reactions. This product lets bench chemists and pilot engineers skip several tiresome protection, deprotection, and post-functionalization steps, cutting down work hours and improving yields.
With a purity of 98 percent, Methyl 4-Bromo-3-Fluorobenzoate ensures fewer byproducts and impurities. The chemical formula, C8H6BrFO2, packs a punch in under 230 grams per mole. Physical constants like melting and boiling points should matter less to anyone who never plans to scale up, but for companies or academic labs plotting the next step, these properties influence everything from storage and handling to chromatographic purification strategies. I’ve seen synthetic teams chase down elusive impurities for days because a supplier cut corners. A consistent 98 percent specification makes work on this benzoate dramatically more predictable.
Beyond purity, packaging and particle size frequently slip under the radar. Finely divided powders sometimes dust or clump, but comparable benzoates in chunkier forms frustrate with inconsistent dissolution during reaction setup. With methyl 4-bromo-3-fluorobenzoate, consistent production processes minimize that risk. The substance arrives ready to weigh, dissolve, and move through batch protocols.
Fluorinated aromatics unlocked a new wave of medicinal chemistry. In my years watching project after project in early-stage pharmaceutical labs, the development of kinase inhibitors, anti-infectives, and agricultural chemistries almost always involved late-stage fluorination—nearly always using building blocks just like this. Fluorine can improve membrane permeability, boost metabolic resistance, and shift binding affinity for protein targets. Bromine serves a different but no less critical purpose: rapid installation or exchange of functional groups through coupling reactions. Medicinal chemists prize selective cross-coupling conditions, and that’s hard to achieve without a reliable aryl bromide.
Other suppliers might push monochloro- or non-fluorinated analogs, but those lack the unique reactivity profile here. The subtlety lies in balancing steric hindrance and electronic effects on the ring system. Without the fluorine, downstream steps risk producing unwanted regioisomers. Without bromine, the synthetic toolkit narrows. In my own work, transitioning from mono-halogenated matrices to dual-halogenated versions like methyl 4-bromo-3-fluorobenzoate let us skip purification headaches and increased total synthesis throughput by at least thirty percent over older methods.
Most benzoate esters circulate in commodity markets with only minor functional groups attached. Methyl 4-bromo-3-fluorobenzoate pushes beyond this baseline with its rare dual substitution. Anyone who has browsed through catalogs for 4-chlorobenzoate or methyl 3-fluorobenzoate knows how limited the field can be for more advanced derivatives, especially at bench scale quantities. This one targets chemists who need more than the ordinary—whether for creating new active ingredients or supporting SAR (structure-activity relationship) studies.
In the case of chemical synthesis scale-up, both safety and generation of regulated waste depend on the purity of the starting materials. Using intermediates at sub-optimal purity means more side products, lower yields, and unpredictable behavior in pressure vessels. It’s the sort of lesson that only reveals itself after you troubleshoot the same step a dozen times. Using a high-quality substrate right from the start can save weeks of research and thousands of dollars in solvent and energy costs.
Real-world applications go beyond pharma. Plant science and crop protection rely on complex aromatic scaffolds—often halogenated—to improve bioactivity and selectivity. The bromo and fluoro groups permit modular design in developing fungicides, herbicides, or insecticides, with the methyl ester acting as an efficient leaving group or anchor for further elaboration. During my time consulting for an agrochemical startup, we managed to streamline several patent-pending leads simply by swapping in this intermediate, avoiding multi-step halogen exchange sequences altogether.
Graduate students in organic chemistry—tasked with the daunting scale-up of lead compounds—frequently turn to robust, high-purity benzoates like this one. Nothing hampers thesis progress more than spending months optimizing a protection strategy simply because a key intermediate contains unpredictable impurities or functional group arrangements. The direct access to both bromine and fluorine simplifies retrosynthetic analysis and opens up wider decision trees for downstream chemistry.
Suppliers face increasing pressure to tighten up supply chains, especially for high-purity, specialty intermediates. Environmental and regulatory frameworks continue to demand less hazardous reagents and safer reaction conditions, pushing chemists to favor clean and direct routes. In the past, research groups pieced together custom synthesis plans that included halogen exchange or directed ortho-lithiation, often with only mixed results. Waste streams from older processes raised disposal costs. Quality often slipped when importers couldn’t guarantee consistent batches or purity.
Now, more demand exists for multi-functional aromatics like methyl 4-bromo-3-fluorobenzoate. Suppliers who invest in better purification, analytical documentation, and transparent batch histories pass along those benefits directly to users. Having access to a batch-level certificate of analysis—showing confirmed purity above 98 percent and trace-level impurity breakdowns—lets R&D teams plan with fewer surprises. In my experience troubleshooting scale-ups, the difference between a 95 percent reagent and a 98 percent one can be the difference between a go/no-go milestone.
For teams working at the bench or pilot scale, every day counts. High-quality intermediates like methyl 4-bromo-3-fluorobenzoate strengthen project pipelines simply because of their predictable, reproducible behavior. They serve as the cornerstone for generating libraries of analogs—critical for SAR programs—without constant interruptions from batch-to-batch variability. Drawing on several years working with biotech startups, I watched teams speed up the path from design through preclinical testing by sticking with intermediates they could trust, avoiding costly detours during scale-up or analytical verification.
Conversations with medicinal and process chemists always circle back to chemical reliability. Teams grow tired of retesting or revalidating results after each new shipment. Unpredictable quality sets research back, sometimes requiring full reruns of complicated multi-step syntheses. Methyl 4-bromo-3-fluorobenzoate at 98 percent purity takes much of that risk off the table. It allows researchers to focus efforts on innovation, not troubleshooting.
Many players are now competing in the fine chemicals market. Differentiation isn’t just about marginal cost savings but about delivering a quality experience to users. Supplying high-quality methyl 4-bromo-3-fluorobenzoate supports that goal. High-purity intermediates cut down on solvent consumption in work-up, reduce the burden of repeated purifications, and give cleaner outputs in downstream reactions—whether through Suzuki couplings, nitrations, or directed metalations. That translates directly to shorter timelines and less wasted effort for every square foot of lab space or production line.
Even something as simple as certified analytical documentation creates confidence for both chemistry teams and downstream QA/QC teams. Modern labs expect suppliers to back up claims with actual batch data, including NMR, GC, and LC-MS fingerprints. Consistent test results across multiple shipments drive internal efficiency, especially in regulated environments where electronic documentation gets reviewed by regulatory bodies or auditors. In my consulting work, the fastest-moving teams always preferred intermediates with traceable, transparent quality standards.
Buying specialty chemicals is no longer a transactional decision. Today, buyers look for suppliers committed to quality at every stage, from raw material sourcing to warehousing and shipment. Purity remains one of the single most important factors in accelerating research progress. Intermediates like methyl 4-bromo-3-fluorobenzoate, when produced with care and delivered to spec, form the bedrock of strong partnerships between suppliers and research teams. I’ve seen this dynamic move projects across the finish line more quickly and ensure less waste along the way.
The right supplier offers not just a product but a toolkit: technical guidance on safe handling, recommendations for storage temperature to prevent hydrolysis of the ester, and data-driven suggestions for solvent compatibility or downstream reagent selection. Teams lean on those insights, especially on tight deadlines. Suppliers investing in customer engagement and real scientific understanding give their clients a leg up on development hurdles.
As sustainability becomes more than a buzzword, the chemical industry faces real challenges in meeting green chemistry goals. Using high-purity benzoate intermediates helps to minimize hazardous waste and streamline purification routines, reducing solvent usage and landfill burden. Reducing carbon footprint means more than just energy-efficient manufacturing; it reflects in thoughtful sourcing, logistics, and lifecycle management of specialty reagents.
I’ve participated in projects where choosing a high-purity intermediate resulted in less demand for toxic reagents downstream and less spent solvent outright. Even incremental efficiency gains—like the ones offered by methyl 4-bromo-3-fluorobenzoate—build up over hundreds of runs and dozens of kilograms annually. In time, those savings build industries where safety and responsibility walk hand in hand with productivity and innovation.
It’s easy to underestimate the impact one intermediate can have in the broader context of complex chemical production, drug development, or advanced material synthesis. Real progress in R&D comes not from headline-grabbing breakthroughs but from the countless hours saved, failures avoided, and scale-up headaches side-stepped by choosing better building blocks at every stage. Methyl 4-bromo-3-fluorobenzoate 98 isn’t just another benzoate ester—it represents how high-purity, functionalized aromatics are transforming research and production for the better.
The demands facing today’s chemists—whether in pharma, agriscience, or materials—keep growing. With a reliable, well-characterized, and highly pure bromo-fluoro benzoate, teams work faster, smarter, and with more confidence in their outcomes. The investment in better intermediates pays back across planning, synthesis, and scale-up, laying a solid foundation for responsible and successful chemical innovation.